ANNX
Price
$5.92
Change
-$0.56 (-8.64%)
Updated
Feb 4, 02:21 PM (EDT)
Capitalization
965.88M
33 days until earnings call
Intraday BUY SELL Signals
OCUL
Price
$8.51
Change
-$0.00 (-0.00%)
Updated
Feb 4, 03:08 PM (EDT)
Capitalization
1.81B
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANNX vs OCUL

Header iconANNX vs OCUL Comparison
Open Charts ANNX vs OCULBanner chart's image
Annexon
Price$5.92
Change-$0.56 (-8.64%)
Volume$1.21K
Capitalization965.88M
Ocular Therapeutix
Price$8.51
Change-$0.00 (-0.00%)
Volume$2.66K
Capitalization1.81B
ANNX vs OCUL Comparison Chart in %
ANNX
Daily Signal:
Gain/Loss:
OCUL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANNX vs. OCUL commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Hold and OCUL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (ANNX: $6.48 vs. OCUL: $8.51)
Brand notoriety: ANNX and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 54% vs. OCUL: 152%
Market capitalization -- ANNX: $965.88M vs. OCUL: $1.81B
ANNX [@Biotechnology] is valued at $965.88M. OCUL’s [@Biotechnology] market capitalization is $1.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 0 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • ANNX’s FA Score: 0 green, 5 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, ANNX is a better buy in the long-term than OCUL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 3 TA indicator(s) are bullish while OCUL’s TA Score has 4 bullish TA indicator(s).

  • ANNX’s TA Score: 3 bullish, 5 bearish.
  • OCUL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ANNX and OCUL are a bad buy in the short-term.

Price Growth

ANNX (@Biotechnology) experienced а -1.37% price change this week, while OCUL (@Biotechnology) price change was -21.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

ANNX is expected to report earnings on Mar 09, 2026.

OCUL is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($1.81B) has a higher market cap than ANNX($966M). ANNX YTD gains are higher at: 29.084 vs. OCUL (-29.901). ANNX has higher annual earnings (EBITDA): -216.47M vs. OCUL (-233.54M). OCUL has more cash in the bank: 345M vs. ANNX (189M). ANNX has less debt than OCUL: ANNX (26.9M) vs OCUL (77M). OCUL has higher revenues than ANNX: OCUL (55.8M) vs ANNX (0).
ANNXOCULANNX / OCUL
Capitalization966M1.81B53%
EBITDA-216.47M-233.54M93%
Gain YTD29.084-29.901-97%
P/E RatioN/AN/A-
Revenue055.8M-
Total Cash189M345M55%
Total Debt26.9M77M35%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANNXOCUL
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 21 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANNX
Daily Signal:
Gain/Loss:
OCUL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LADFX29.260.06
+0.21%
Lord Abbett Developing Growth F
LEQCX9.770.02
+0.21%
LoCorr Dynamic Opportunity C
PMIVX11.46-0.01
-0.09%
Putnam Multi-Asset Income R6
DCUIX14.90-0.16
-1.06%
DWS CROCI US Inst
UANQX60.36-0.95
-1.55%
Victory Nasdaq 100 Index Class A

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with OCUL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
+1.57%
OCUL - ANNX
44%
Loosely correlated
-6.99%
NRIX - ANNX
43%
Loosely correlated
-1.76%
IDYA - ANNX
43%
Loosely correlated
+0.50%
ZYME - ANNX
42%
Loosely correlated
+1.17%
CRNX - ANNX
42%
Loosely correlated
+1.24%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with WVE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
-6.99%
WVE - OCUL
54%
Loosely correlated
+2.01%
NRIX - OCUL
53%
Loosely correlated
-1.76%
NUVL - OCUL
53%
Loosely correlated
+2.12%
ERAS - OCUL
53%
Loosely correlated
-0.24%
DYN - OCUL
52%
Loosely correlated
+1.07%
More